Validity and reliability of measurement instruments used in research

American Journal of Health-System Pharmacy

Volumn 65, Issue 23, 2008, Pages 2276-2284

  Kimberlin, Carole L ^a   Winterstein, Almut G ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Control, quality; Data collection; Errors; Methodology; Research

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; EZETIMIBE; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ANALYTICAL ERROR; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; CONSTRUCT VALIDITY; CONTENT VALIDITY; DATA COLLECTION METHOD; DRUG MEGADOSE; FAMILIAL HYPERCHOLESTEROLEMIA; HEALTH SERVICES RESEARCH; HUMAN; MEASUREMENT; METHODOLOGY; OUTCOMES RESEARCH; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY CONTROL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; RESEARCH; REVIEW; SCORING SYSTEM; SELF REPORT; SOCIOLOGY; TREATMENT RESPONSE; VALIDITY;

EID: 57149104201     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070364     Document Type: Review

References (28)

1. Crocker L, Algina J. Introduction to classical and modern test theory. Orlando, FL: Harcourt Brace Jovanovich; 1986:1-527.
2. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994:251.
3. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16:297-334.
4. DeVellis RF. Classical test theory. Med Care. 2006; 44(11, suppl 3):S50-9.
5. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960; 20:37-46.
6. Marshall GN, Hays RD. The Patient Satisfaction Questionnaire Short-Form (PSQ-18). Santa Monica, CA: RAND; 1994.
7. Cambell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959; 56:81-105.
8. Watkins C, Daniels L, Jack C et al. Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study. BMJ. 2001; 17:1159.
9. Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences. Mahwah, NJ: Lawrence Erlbaum; 2001:1-288.
10. Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of item response theory. Newbury Park, CA: Sage; 1991:1-153.
11. Smith EV, Smith RM. Introduction to Rasch measurement. Maple Grove, MN: JAM; 2004.
12. National Institutes of Health. PROMIS: Patient-Reported Outcomes Measurement Information System. www.nihpromis.org/default.aspx (accessed 2008 Jun 2).
13. Schwarz N. Self-reports: how the questions shape the answers. Am Psychol. 1999; 54:93-105.
14. Schwarz N, Oyserman D. Asking questions about behavior: cognition, communication and questionnaire construction. Am J Eval. 2001; 22:127-60.
15. Sudman S, Bradburn N, Schwarz N. Thinking about answers: the application of cognitive processes to survey methodology. San Francisco: Jossey-Bass; 1996:1-304.
16. Olsen J. Epidemiology deserves better questionnaires. Int J Epidemiol. 1998; 27: 935.
17. Beiderbeck AB, Sturkenboom MC, Coebergh JW et al. Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up. J Clin Epidemiol. 2004; 57:973-7.
18. Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf. 2002; 11:663-9.
19. Korthuis PT, Asch S, Mancewicz M et al. Measuring medication: do interviews agree with medical record and pharmacy data? Med Care. 2002; 40:1270-82.
20. Tripepi G, Jager KJ, Dekker FW et al. Bias in clinical research. Kidney Int. 2008; 73:148-53.
21. Gilbert EH, Lowenstein SR, Koziol-McLain J et al. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996; 27: 305-8.
22. Yawn BP, Wollan P. Interrater reliability: completing the methods description in medical records review studies. Am J Epidemiol. 2005; 161:974-7.
23. Reisch LM, Fosse JS, Beverly K et al. Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol. 2003; 157:546-51.
24. Gearing RE, Mian IA, Barber J et al. A methodology for conducting retrospective chart review research in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2006; 15:126-34.
25. Temple RJ. A regulatory authority's opinion about surrogate endpoints. In: Nimmo WS, Tucker GT, eds. Clinical measurement in drug evaluation. New York: Wiley; 1995:1-22.
26. D'Agostino RB Jr. The slippery slope of surrogate outcomes. Curr Control Trials Cardiovasc Med. 2000; 1:76-8.
27. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998; 280:605-13.
28. Katelein JJ, Akdim F, Stroes ES et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl Med. 2008; 358:1431-43. [Erratum, N Engl J Med. 2008; 358:1977.]